- Home
- DXCM vs TROW Comparison
DXCM vs TROW Comparison
Compare DXCM & TROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DXCM | TROW |
|---|---|---|
| Founded | 1999 | 1937 |
| Country | United States | United States |
| Employees | N/A | 4802 |
| Industry | Medical/Dental Instruments | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.4B | 26.1B |
| IPO Year | 2005 | 2000 |
Fundamental Metrics
Financial Performance| Metric | DXCM | TROW |
|---|---|---|
| Price | $89.64 | $104.18 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 21 | 11 |
| Target Price | $85.33 | ★ $98.00 |
| AVG Volume (30 Days) | ★ 3.3M | 1.2M |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 5.18% |
| EPS Growth | ★ 47.18 | 0.98 |
| EPS | 1.15 | ★ 5.10 |
| Revenue | N/A | ★ $2,370,700,000.00 |
| Revenue This Year | $14.46 | $5.48 |
| Revenue Next Year | $12.31 | $1.56 |
| P/E Ratio | $76.46 | ★ $20.16 |
| Revenue Growth | N/A | ★ 26.65 |
| 52 Week Low | $54.11 | $85.22 |
| 52 Week High | $92.59 | $122.00 |
Technical Indicators
Market Signals| Indicator | DXCM | TROW |
|---|---|---|
| Relative Strength Index (RSI) | 58.17 | 30.80 |
| Support Level | $87.51 | $101.55 |
| Resistance Level | $92.46 | $107.09 |
| Average True Range (ATR) | 2.26 | 1.98 |
| MACD | -0.28 | -0.59 |
| Stochastic Oscillator | 68.74 | 22.24 |
Price Performance
Historical ComparisonAbout DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
About TROW T. Rowe Price Group Inc.
T. Rowe Price provides asset management services for individual and institutional investors. It offers a broad range of no-load US and international stock, hybrid, bond, and money market funds. At the end of May 2026, the firm had $1.892 trillion in managed assets, composed of equity (49%), balanced (37%), fixed-income and money market (11%), and alternative (3%) offerings. Approximately two-thirds of managed assets are held in retirement-based accounts, which provide T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a US-based asset manager, deriving less than 10% of its AUM from overseas.